Quisel John D
Chief Executive Officer at IRON; EVP, Chief Business Officer at ACCELERON PHARMA INC
- Sold, on record
- $25.3M
- Dollars the filings state
- Form 4 sales
- 40
- Latest Aug 17, 2026
- Form 144 notices
- 7
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- IRONDisc Medicine, Inc.Chief Executive Officer
- ACCELERON PHARMA INCEVP, Chief Business Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- IRON244,461 shares
- ACCELERON PHARMA INC218,730 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale IRONRoutineJul 9, 2025 2025
Sold 34,800 shares at $55.33 ($1.9M)
Quisel John D, Chief Executive Officer
10b5-1 planSold 17.7% of holdings ($10.9M position)161,828 shares left2.7x usual sizeFollows a Form 144Filing
- 2 Form 144 notice IRONNoticeDec 11, 2025 +155 days
Filed to sell 40,000 shares ($3.7M)
Quisel John D, Director, Officer
10b5-1 plan3.1x usual sizeFiling
- 3 Form 4 sale IRONUnusualDec 11, 2025 same day
Sold 40,000 shares at $93.05 ($3.7M)
Quisel John D, Chief Executive Officer
10b5-1 planSold 18.9% of holdings ($19.7M position)171,828 shares left3.1x usual sizeFollows a Form 144Filing
- 4 Form 4 sale IRONNo planFeb 17, 2026 +68 days
Sold 13,264 shares at $62.86 ($834k)
Quisel John D, Chief Executive Officer
No 10b5-1 planSold 5.5% of holdings ($15M position)226,064 shares left1x usual sizeFollows a Form 144Filing
- 5 Form 144 notice IRONNoticeFeb 17, 2026 same day
Filed to sell 13,264 shares ($742k)
Quisel John D, Officer, Director
No 10b5-1 plan1x usual sizeFiling
- 6 Form 4 sale IRONRoutineJun 18, 2026 +121 days
Sold 34,000 shares at $70.22 ($2.4M)
Quisel John D, Chief Executive Officer
10b5-1 planSold 13.1% of holdings ($18.3M position)226,064 shares left2.6x usual sizeFiling
- 7 Form 4 sale IRONRoutineJul 13, 2026 +25 days
Sold 33,000 shares at $74.96 ($2.5M)
Quisel John D, Chief Executive Officer
10b5-1 planSold 12.7% of holdings ($19.4M position)226,064 shares left2.5x usual sizeFiling
- 8 Form 4 sale IRONRoutineAug 17, 2026 +35 days
Sold 33,000 shares at $79.15 ($2.6M)
Quisel John D, Chief Executive Officer
10b5-1 planSold 12.7% of holdings ($20.5M position)226,064 shares left2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (47)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Aug 18, 2026 | IRON | Chief Executive Officer | Form 4 sale | 33,000 | $2.6M | 12.7% | Routine | SEC |
| Jul 13, 2026 | Jul 14, 2026 | IRON | Chief Executive Officer | Form 4 sale | 33,000 | $2.5M | 12.7% | Routine | SEC |
| Jun 18, 2026 | Jun 23, 2026 | IRON | Chief Executive Officer | Form 4 sale | 34,000 | $2.4M | 13.1% | Routine | SEC |
| Feb 17, 2026 | Feb 17, 2026 | IRON | Officer, Director | Form 144 notice | 13,264 | $742k | Notice | SEC | |
| Feb 17, 2026 | Feb 17, 2026 | IRON | Chief Executive Officer | Form 4 sale | 13,264 | $834k | 5.5% | No plan | SEC |
| Dec 11, 2025 | Dec 15, 2025 | IRON | Chief Executive Officer | Form 4 sale | 40,000 | $3.7M | 18.9% | Unusual | SEC |
| Dec 11, 2025 | Dec 11, 2025 | IRON | Director, Officer | Form 144 notice | 40,000 | $3.7M | Notice | SEC | |
| Jul 9, 2025 | Jul 11, 2025 | IRON | Chief Executive Officer | Form 4 sale | 34,800 | $1.9M | 17.7% | Routine | SEC |
| Jul 9, 2025 | Jul 9, 2025 | IRON | Director, Officer | Form 144 notice | 34,800 | $1.8M | Notice | SEC | |
| Jul 3, 2025 | Jul 8, 2025 | IRON | Chief Executive Officer | Form 4 sale | 5,200 | $286k | 3.1% | Routine | SEC |
| Jul 3, 2025 | Jul 3, 2025 | IRON | Director, Officer | Form 144 notice | 5,200 | $276k | Notice | SEC | |
| Feb 18, 2025 | Feb 20, 2025 | IRON | Chief Executive Officer | Form 4 sale | 5,574 | $304k | 3.5% | No plan | SEC |
| Dec 30, 2024 | Jan 2, 2025 | IRON | Chief Executive Officer | Form 4 sale | 13,012 | $806k | 15.3% | Routine | SEC |
| Dec 30, 2024 | Dec 30, 2024 | IRON | Director, Officer | Form 144 notice | 13,012 | $834k | Notice | SEC | |
| Dec 23, 2024 | Dec 26, 2024 | IRON | Chief Executive Officer | Form 4 sale | 19,820 | $1.3M | 21.6% | Routine | SEC |
| Dec 23, 2024 | Dec 23, 2024 | IRON | Director, Officer | Form 144 notice | 19,820 | $1.3M | Notice | SEC | |
| Dec 16, 2024 | Dec 18, 2024 | IRON | Chief Executive Officer | Form 4 sale | 12,791 | $844k | 15.1% | Routine | SEC |
| Dec 16, 2024 | Dec 16, 2024 | IRON | Director, Officer | Form 144 notice | 12,791 | $830k | Notice | SEC | |
| Jan 2, 2020 | Jan 3, 2020 | ACCELERON PHARMA INC | EVP, Chief Business Officer | Form 4 sale | 5,842 | $307k | 9.9% | Plan not stated | SEC |
| Sep 10, 2019 | Sep 10, 2019 | ACCELERON PHARMA INC | EVP, Chief Business Officer | Form 4 sale | 3,584 | $162k | 5.7% | Plan not stated | SEC |
| Apr 9, 2019 | Apr 11, 2019 | ACCELERON PHARMA INC | EVP, CBO and Secretary | Form 4 sale | 3,622 | $162k | 6.3% | Plan not stated | SEC |
| Jan 2, 2019 | Jan 4, 2019 | ACCELERON PHARMA INC | EVP, CBO and Secretary | Form 4 sale | 5,942 | $254k | 10.1% | Plan not stated | SEC |
| Apr 3, 2018 | Apr 4, 2018 | ACCELERON PHARMA INC | SVP, Corp. Dev., GC & Sec. | Form 4 sale | 1,204 | $46k | 2.1% | Plan not stated | SEC |
| Jan 2, 2018 | Jan 4, 2018 | ACCELERON PHARMA INC | SVP, Corp. Dev., GC & Sec. | Form 4 sale | 4,333 | $184k | 7.6% | Plan not stated | SEC |
| Sep 13, 2017 | Sep 14, 2017 | ACCELERON PHARMA INC | SVP, Corp. Dev., GC & Sec. | Form 4 sale | 5,113 | $196k | 8.2% | Plan not stated | SEC |
| Jan 4, 2017 | Jan 6, 2017 | ACCELERON PHARMA INC | SVP, Bus. Dev., GC & Secretary | Form 4 sale | 1,700 | $47k | 3.0% | Plan not stated | SEC |
| Sep 21, 2016 | Sep 23, 2016 | ACCELERON PHARMA INC | SVP, Bus. Dev., GC & Secretary | Form 4 sale | 45,952 | $1.7M | 45.0% | Unusual | SEC |
| Sep 12, 2016 | Sep 13, 2016 | ACCELERON PHARMA INC | SVP, Bus. Dev., GC & Secretary | Form 4 sale | 21,438 | $689k | 22.0% | Unusual | SEC |
| Sep 14, 2015 | Sep 16, 2015 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 5,500 | $183k | 6.7% | Plan not stated | SEC |
| Aug 14, 2015 | Aug 17, 2015 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 5,500 | $170k | 13.2% | Plan not stated | SEC |
| Jul 14, 2015 | Jul 16, 2015 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 5,500 | $165k | 19.5% | Plan not stated | SEC |
| Jun 15, 2015 | Jun 16, 2015 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 5,500 | $171k | 26.8% | Unusual | SEC |
| May 14, 2015 | May 18, 2015 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 5,500 | $174k | 26.8% | Unusual | SEC |
| Mar 16, 2015 | Mar 17, 2015 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 9,500 | $390k | 38.8% | Unusual | SEC |
| Mar 4, 2015 | Mar 6, 2015 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 9,500 | $387k | 38.8% | Unusual | SEC |
| Jan 14, 2015 | Jan 16, 2015 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 9,500 | $380k | 38.8% | Unusual | SEC |
| Dec 12, 2014 | Dec 16, 2014 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 4,000 | $165k | 100.0% | Unusual | SEC |
| Nov 14, 2014 | Nov 18, 2014 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 4,000 | $134k | 100.0% | Unusual | SEC |
| Nov 12, 2014 | Nov 14, 2014 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 5,000 | $166k | 100.0% | Unusual | SEC |
| Oct 14, 2014 | Oct 16, 2014 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 4,000 | $116k | 100.0% | Unusual | SEC |
| Sep 30, 2014 | Oct 1, 2014 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 7,000 | $210k | 100.0% | Unusual | SEC |
| Sep 12, 2014 | Sep 12, 2014 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 2,000 | $51k | 100.0% | Unusual | SEC |
| Aug 14, 2014 | Aug 15, 2014 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 13,000 | $390k | 100.0% | Unusual | SEC |
| Jul 14, 2014 | Jul 16, 2014 | ACCELERON PHARMA INC | SVP Gen. Counsel & Secretary | Form 4 sale | 5,000 | $149k | 100.0% | Unusual | SEC |
| Jun 13, 2014 | Jun 17, 2014 | ACCELERON PHARMA INC | VP General Counsel & Secretary | Form 4 sale | 9,000 | $305k | 100.0% | Unusual | SEC |
| May 19, 2014 | May 21, 2014 | ACCELERON PHARMA INC | VP General Counsel & Secretary | Form 4 sale | 9,000 | $283k | 100.0% | Unusual | SEC |
| Apr 22, 2014 | Apr 24, 2014 | ACCELERON PHARMA INC | VP General Counsel & Secretary | Form 4 sale | 2,000 | $72k | 100.0% | Unusual | SEC |